Literature DB >> 22454520

A novel regulatory mechanism links PLCγ1 to PDK1.

Claudio Raimondi1, Anissa Chikh, Ann P Wheeler, Tania Maffucci, Marco Falasca.   

Abstract

3-Phosphoinositide-dependent protein kinase-1 (PDK1) and phospholipase C (PLC)γ1 are two key enzymes in signal transduction that control several intracellular processes. Despite the fact that PLCγ1 has been investigated for several years, the mechanisms of activation of this enzyme are still not completely clear. Similarly, although PDK1 has been mostly investigated for its role in activation of Akt, a crucial enzyme in regulation of several cellular processes, it has become evident recently that the role of PDK1 in physiological and pathological conditions is not limited to Akt activation. Here we demonstrate that PDK1 regulates PLCγ1 activation in a mechanism involving association of the two enzymes and modulation of PLCγ1 tyrosine phosphorylation. We further show that this novel PDK1-PLCγ1 pathway is important for cancer cell invasion. The identification of a PDK1-PLCγ1 pathway reveals the existence of a previously undetected link between two of the most important enzymes in signal transduction. This is likely to have profound consequences for our understanding of several cellular functions that are dependent on phosphoinositides and controlled by PDK1 and PLCγ1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454520      PMCID: PMC3434861          DOI: 10.1242/jcs.100511

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  29 in total

1.  Activation of phospholipase C-gamma by phosphatidylinositol 3,4,5-trisphosphate.

Authors:  Y S Bae; L G Cantley; C S Chen; S R Kim; K S Kwon; S G Rhee
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

2.  The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.

Authors:  M R Williams; J S Arthur; A Balendran; J van der Kaay; V Poli; P Cohen; D R Alessi
Journal:  Curr Biol       Date:  2000-04-20       Impact factor: 10.834

3.  Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas.

Authors:  C L Arteaga; M D Johnson; G Todderud; R J Coffey; G Carpenter; D L Page
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Mechanism of B-cell receptor-induced phosphorylation and activation of phospholipase C-gamma2.

Authors:  Yeun Ju Kim; Fujio Sekiya; Benoit Poulin; Yun Soo Bae; Sue Goo Rhee
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

5.  Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting.

Authors:  M Falasca; S K Logan; V P Lehto; G Baccante; M A Lemmon; J Schlessinger
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

6.  The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration.

Authors:  Enza Piccolo; Pasquale F Innominato; Maria A Mariggio; Tania Maffucci; Stefano Iacobelli; Marco Falasca
Journal:  Oncogene       Date:  2002-09-19       Impact factor: 9.867

Review 7.  Phospholipase C-gamma1 in tumor progression.

Authors:  Alan Wells; Jennifer Rubin Grandis
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  Mechanism of tyrosine phosphorylation and activation of phospholipase C-gamma 1. Tyrosine 783 phosphorylation is not sufficient for lipase activation.

Authors:  Fujio Sekiya; Benoit Poulin; Yeun Ju Kim; Sue Goo Rhee
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

9.  Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation.

Authors:  Hideki Yamaguchi; Shuhei Yoshida; Emi Muroi; Nachi Yoshida; Masahiro Kawamura; Zen Kouchi; Yoshikazu Nakamura; Ryuichi Sakai; Kiyoko Fukami
Journal:  J Cell Biol       Date:  2011-06-27       Impact factor: 10.539

10.  A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation.

Authors:  Elizabeth Clayton; Giuseppe Bardi; Sarah E Bell; David Chantry; C Peter Downes; Alexander Gray; Lisa A Humphries; David Rawlings; Helen Reynolds; Elena Vigorito; Martin Turner
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  19 in total

1.  Synthesis of Novel 3,5-Disubstituted-2-oxindole Derivatives As Antitumor Agents against Human Nonsmall Cell Lung Cancer.

Authors:  Giulia Nesi; Simona Sestito; Valentina Mey; Simona Ricciardi; Marco Falasca; Romano Danesi; Annalina Lapucci; Maria C Breschi; Stefano Fogli; Simona Rapposelli
Journal:  ACS Med Chem Lett       Date:  2013-10-18       Impact factor: 4.345

2.  Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.

Authors:  Zhonglu Yang; Zhiyi Wu; Tao Liu; Lei Han; Chunhui Wang; Bo Yang; Fei Zheng
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

3.  A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma.

Authors:  Mai Q Nguyen; Nicole A Wilski; Timothy J Purwin; Weijia Cai; Mégane Vernon; Manoela Tiago; Andrew E Aplin
Journal:  Cancer Res       Date:  2022-07-18       Impact factor: 13.312

4.  3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner.

Authors:  Paolo Armando Gagliardi; Laura di Blasio; Francesca Orso; Giorgio Seano; Roberto Sessa; Daniela Taverna; Federico Bussolino; Luca Primo
Journal:  Neoplasia       Date:  2012-08       Impact factor: 5.715

Review 5.  Emerging roles of PLCγ1 in endothelial biology.

Authors:  Dongying Chen; Michael Simons
Journal:  Sci Signal       Date:  2021-08-03       Impact factor: 8.192

6.  Platelet-derived growth factor-induced Akt phosphorylation requires mTOR/Rictor and phospholipase C-γ1, whereas S6 phosphorylation depends on mTOR/Raptor and phospholipase D.

Authors:  Masoud Razmara; Carl-Henrik Heldin; Johan Lennartsson
Journal:  Cell Commun Signal       Date:  2013-01-11       Impact factor: 5.712

7.  Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors.

Authors:  Xiao-jun Qian; Yun-tian Li; Yan Yu; Fen Yang; Rong Deng; Jiao Ji; Lin Jiao; Xuan Li; Rui-Yan Wu; Wen-Dan Chen; Gong-Kan Feng; Xiao-Feng Zhu
Journal:  Oncotarget       Date:  2015-03-10

Review 8.  3-Phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer.

Authors:  Chanse Fyffe; Marco Falasca
Journal:  Cancer Manag Res       Date:  2013-08-23       Impact factor: 3.989

9.  PDK1-mediated activation of MRCKα regulates directional cell migration and lamellipodia retraction.

Authors:  Paolo Armando Gagliardi; Laura di Blasio; Alberto Puliafito; Giorgio Seano; Roberto Sessa; Federica Chianale; Thomas Leung; Federico Bussolino; Luca Primo
Journal:  J Cell Biol       Date:  2014-08-04       Impact factor: 10.539

10.  A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.

Authors:  Claudio Raimondi; Veronique Calleja; Riccardo Ferro; Alessandro Fantin; Andrew M Riley; Barry V L Potter; Caroline H Brennan; Tania Maffucci; Banafshé Larijani; Marco Falasca
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.